European venture capital firms closed multiple €150M+ funds targeting deeptech infrastructure in recent months, signaling a structural shift toward specialized sector investing. Defense tech, AI compute infrastructure, and autonomous systems now attract institutional-grade capital as the market abandons generalist growth strategies.
Investors describe the current environment as a 'barbell equilibrium'—capital concentrates at two extremes. One end funds early-stage deeptech with breakthrough potential. The other backs proven infrastructure plays in robotics, life sciences, and defense. The traditional mid-stage growth investing has collapsed.
This polarization reflects lessons from 2023-2024's capital drought. Generalist funds betting on broad recovery got crushed. Specialized funds with sector expertise and patient capital survived. Oleg Khuaenov, a European tech investor, argues the market 'enters the new year not in recovery, but in equilibrium' where only category-specific strategies scale.
Defense tech exemplifies the trend. Multiple European funds raised €150M+ specifically for dual-use technologies, cybersecurity infrastructure, and autonomous defense systems. These aren't speculative bets—they're infrastructure plays with government contracts and predictable revenue.
AI compute infrastructure follows similar patterns. Gate Ventures identifies mining firms transitioning to AI compute infrastructure across APAC, Central Asia, and the Middle East as undervalued infrastructure plays. The thesis: specialized compute infrastructure for AI training carries less risk than consumer AI applications.
Autonomous systems draw capital for similar reasons. Uber plans commercial robotaxi service in the Bay Area by late 2026, requiring massive infrastructure investment. European investors fund the sensor networks, fleet management systems, and edge computing infrastructure enabling autonomous operations—not the vehicles themselves.
Life sciences deeptech attracts infrastructure capital through specialized bridging mechanisms. These funds finance the gap between research breakthroughs and commercial validation—traditionally a valley of death for European biotech.
The shift has consequences. Founders building horizontal platforms or generalist SaaS face sparse funding. Those building vertical infrastructure for specific deeptech categories—battery manufacturing systems, quantum computing infrastructure, biotech manufacturing platforms—find receptive investors.
European deeptech now mirrors the broader VC market: specialized, institutional, and focused on infrastructure over applications. The barbell equilibrium appears durable, reshaping what gets funded and how European deeptech scales.